Mechanisms of toxicity of 3'-azido-3'-deoxythymidine. Its interaction with adenylate kinase. 1994

M Barile, and D Valenti, and G A Hobbs, and M F Abruzzese, and S A Keilbaugh, and S Passarella, and E Quagliariello, and M V Simpson
Dipartimento di Biochimica e Biologia Molecolare, Università degli Studi, Bari, Italy.

Recent experiments from our laboratory have indicated that the inhibitory effect of 3'-azido-3'-deoxythymidine (AZT) on oxidative phosphorylation may occur directly, in addition to being brought about by its inhibition of mtDNA replication. We report here studies on the effect of AZT on adenylate kinase, an enzyme crucial to oxidative phosphorylation. AZT decreased the aromatic residues fluorescence of rabbit muscle adenylate kinase, indicating binding of AZT to the enzyme. Of three other enzymes studied as controls, AZT bound only to those that possessed ATP/ADP binding sites. Up to concentrations of 15 microM, AZT was a more potent effector of fluorescence quenching than were ATP, ADP, AMP, and the AZT control, deoxythymidine. AZT strongly inhibited adenylate kinase in the direction of ATP synthesis (Ki, 8 microM), the inhibition being of the partial competitive type, whereas deoxythymidine inhibition, also partially competitive, was much weaker (Ki, 90 microM). When measured in the direction of ADP synthesis, AZT failed to demonstrate any inhibition at concentrations up to 10 microM. Experiments on isolated intact rat liver mitochondria with the enzyme activity measured in both directions confirmed the isolated enzyme results. Respiratory control by these mitochondria was not affected by AZT. The finding of AZT affinity for ATP/ADP binding sites may open new avenues of approach to the study of AZT toxicity.

UI MeSH Term Description Entries
D008297 Male Males
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D010085 Oxidative Phosphorylation Electron transfer through the cytochrome system liberating free energy which is transformed into high-energy phosphate bonds. Phosphorylation, Oxidative,Oxidative Phosphorylations,Phosphorylations, Oxidative
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000244 Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. ADP,Adenosine Pyrophosphate,Magnesium ADP,MgADP,Adenosine 5'-Pyrophosphate,5'-Pyrophosphate, Adenosine,ADP, Magnesium,Adenosine 5' Pyrophosphate,Diphosphate, Adenosine,Pyrophosphate, Adenosine
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000263 Adenylate Kinase An enzyme that catalyzes the phosphorylation of AMP to ADP in the presence of ATP or inorganic triphosphate. EC 2.7.4.3. Myokinase,AMP Kinase,ATP-AMP Phosphotransferase,ATP-AMP Transphosphorylase,Adenylokinase,ATP AMP Phosphotransferase,ATP AMP Transphosphorylase,Kinase, AMP,Kinase, Adenylate,Phosphotransferase, ATP-AMP,Transphosphorylase, ATP-AMP
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M Barile, and D Valenti, and G A Hobbs, and M F Abruzzese, and S A Keilbaugh, and S Passarella, and E Quagliariello, and M V Simpson
April 1988, Acta crystallographica. Section C, Crystal structure communications,
M Barile, and D Valenti, and G A Hobbs, and M F Abruzzese, and S A Keilbaugh, and S Passarella, and E Quagliariello, and M V Simpson
September 1990, International journal of cell cloning,
M Barile, and D Valenti, and G A Hobbs, and M F Abruzzese, and S A Keilbaugh, and S Passarella, and E Quagliariello, and M V Simpson
June 1989, Antimicrobial agents and chemotherapy,
M Barile, and D Valenti, and G A Hobbs, and M F Abruzzese, and S A Keilbaugh, and S Passarella, and E Quagliariello, and M V Simpson
September 1993, Antimicrobial agents and chemotherapy,
M Barile, and D Valenti, and G A Hobbs, and M F Abruzzese, and S A Keilbaugh, and S Passarella, and E Quagliariello, and M V Simpson
January 1993, Oncology research,
M Barile, and D Valenti, and G A Hobbs, and M F Abruzzese, and S A Keilbaugh, and S Passarella, and E Quagliariello, and M V Simpson
January 2003, Biopolymers,
M Barile, and D Valenti, and G A Hobbs, and M F Abruzzese, and S A Keilbaugh, and S Passarella, and E Quagliariello, and M V Simpson
September 1988, Biochemical and biophysical research communications,
M Barile, and D Valenti, and G A Hobbs, and M F Abruzzese, and S A Keilbaugh, and S Passarella, and E Quagliariello, and M V Simpson
April 1991, The Journal of pharmacology and experimental therapeutics,
M Barile, and D Valenti, and G A Hobbs, and M F Abruzzese, and S A Keilbaugh, and S Passarella, and E Quagliariello, and M V Simpson
January 1995, Pharmacotherapy,
M Barile, and D Valenti, and G A Hobbs, and M F Abruzzese, and S A Keilbaugh, and S Passarella, and E Quagliariello, and M V Simpson
February 1990, AIDS research and human retroviruses,
Copied contents to your clipboard!